Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals.

Abstract

BACKGROUND AND AIMS Direct-acting antivirals (DAAs) dramatically improve the sustained virological response (SVR) of chronic hepatitis C (CHC) patients. However, continuous liver damage after SVR may be a risk of hepatocellular carcinoma (HCC). We clarified pretreatment characteristics related to sustained liver damage after SVR. METHODS A total of 286… (More)

DOI: 10.1159/000480148

Topics

Chemical and Drug Induced Liver Injury
Hepatitis C, Chronic
Hepatitis, Chronic
Alanine Transaminase
Liver carcinoma
Fatty Liver
Alanine
Hepatitis C
Transaminases
Total Peripheral Resistance

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Cited By

Sorry, we couldn't extract any citations for this paper.

References

Sorry, we couldn't extract any references for this paper.

Slides referencing similar topics

Chronic Hepatitis C Overview and Update
Oct 27, 2017
Hepatitis C Virus (HCV) Outcomes after Treatment with Direct Acting Agents (DAA) in Patients with Bleeding Disorders
Christopher Walsh + 1 • Aug 27, 2017
Treatment of Hepatitis C in Patients with Renal Insufficiency
Robert G. Gish + 1 • Oct 17, 2017
Show More